MorphoSys AG buy OldOrangeEyes
Start price
29.11.23
/
50%
€20.27
Target price
29.11.24
-
Performance (%)
232.51%
End price
30.11.24
-
Summary
This prediction is currently being closed. With a performance of 232.51% the BUY prediction by OldOrangeEyes is a big success. OldOrangeEyes has 50% into this predictionMorphoSys is a German biopharmaceutical company that develops innovative therapies for the treatment of cancer, autoimmune diseases, and other serious illnesses. The company specializes in developing monoclonal antibodies, which are highly specific and targeted therapies that recognize and bind to specific cancer cells or disease-causing proteins in the body. MorphoSys has a diverse pipeline of products in various stages of development, including several drugs that have shown promising results in clinical trials. The company is listed on the Frankfurt and NASDAQ stock exchanges and has a market capitalization of over $4 billion.
Performance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| MorphoSys AG | - | - | - |
| iShares Core DAX® | -0.793% | 4.201% | 19.951% |
| iShares Nasdaq 100 | -2.376% | 0.857% | 4.704% |
| iShares Nikkei 225® | -2.701% | -0.147% | 12.609% |
| iShares S&P 500 | -1.689% | 1.244% | 3.144% |
Comments by OldOrangeEyes for this prediction
In the thread Trading Morphosys AG
Die von OldOrangeEyes gewählte maximale Laufzeit wurde überschritten